NEJM· @NEJM · X·· 8 小时前AI 评分52
AI 导读
NEJM 公布 2026 年 10 月 1 日刊内容，包含四项 III 期试验：阿托伐他汀用于老年人（STAREE 试验）、Obexelimab 治疗 IgG4 相关疾病（INDIGO 试验）。
正文
New in the October 1, 2026, issue of NEJM:
Atorvastatin in Older Adults (STAREE trial) https://nej.md/4ghHPSC
Obexelimab for the Treatment of IgG4-Related Disease (phase 3 INDIGO trial) https://nej.md/4fKYQG4
Giredestrant–Everolimus in Advanced Breast Cancer (phase 3 evERA Breast Cancer trial) https://nej.md/47ryfbF
Oral Islatravir–Lenacapavir for HIV-1 Treatment (phase 3 ISLEND-1 trial) https://nej.md/4b4s7sh
Subscribe to NEJM for the latest medical research: https://nej.md/subscribe
来源：NEJM · x.com